Introduction
Mobilization of lipids through lipolysis in fat cells is a key event in energy homeostasis.
Lipolysis is disturbed in many insulin resistant disorders such as obesity and polycystic ovary syndrome (PCOS), which in turn are important risk factors for type 2 diabetes mellitus (1) .
Lipolysis in fat cells is under intense hormonal control. Hormone sensitive lipase (HSL) has for decades been regarded as the main regulatory step in mammal lipolysis (14) . It is stimulated by catecholamines and other prolipolytic hormones and inhibited by insulin.
Lipids are mainly stored in fat cells as triglycerides (TG). When lipolysis is stimulated, TG are usually completely hydrolyzed into glycerol and free fatty acids (FFA). In rodents and humans there is also some partial lipolysis leading to the formation of diglycerides (DG) and FFA but not glycerol (2, 29) . HSL hydrolyzes both TG and DG, although the affinity for the latter is ten-fold higher (9) . Therefore, incomplete hydrolysis of TG to DG during lipolysis may be due to the lower substrate affinity of HSL to TG, rather than the existence of a specific TG lipase with a different regulation than HSL. The pivotal role of HSL in adipocyte lipolysis was first questioned when data from HSL -/-mice were reported. The animals showed normal weight, had markedly blunted stimulated fat cell lipolysis but retained residual basal lipolysis (26, 32) . Subsequent analysis demonstrated that knockout animals displayed an accumulation of DG in several tissues (12) , suggesting that although HSL may catalyze the rate-limiting step in TG hydrolysis, the major physiological substrates are DG and not TG.
Recently, a novel triglyceride-specific lipase has been isolated and termed adipose triglyceride lipase (ATGL-the term used in this work) (34) , desnutrin (33) and iPLA 2 
(15).
The murine ATGL gene codes for a 486 amino acid long protein while the human homologue, displaying 86% identity, codes for a 506 amino acid protein. Studies in rodents have shown that ATGL is predominantly expressed in white and brown adipose tissue although significant levels are also expressed in cardiac and skeletal muscle. The enzyme displays substrate specificity for TG but unlike HSL, activation of ATGL is not dependent on phosphorylation events. Further studies have shown that ATGL expression is increased by fasting (33) and decreased by insulin (16) . Recently, the phenotype of mice homozygous for a null mutation in the ATGL gene was described (11) . In these animals both basal and catecholamine-stimulated lipolysis were markedly decreased and this was true for both glycerol and FFA release (11) .
ATGL -/-mice display a slightly larger white adipose tissue (WAT) mass but more importantly, a massive TG accumulation in non-adipose tissue, in particular heart muscle.
This results in a rapidly developing heart failure and reduced life span. Furthermore, the Page 3 of 29 animals display a defective cold adaptation indicating that ATGL is essential to provide FFAs to fuel thermogenesis. A reduction in FFA availability results in an increase in glucose utilization which could explain the increase in glucose tolerance and insulin sensitivity observed in these animals. Finally, it was recently demonstrated in immortalized non-human cell lines that the lipid droplet associated protein CGI-58 was essential for ATGL activity although the molecular mechanisms remain to be elucidated (20) . In summary, data from animal studies suggest that ATGL is essential for basal and stimulated lipolysis and of major importance for energy homeostasis. Accordingly, in a mouse fat cell line, over expression of ATGL resulted in increased basal and stimulated lipolysis, while inhibition by RNA interference (RNAi) had the opposite effect (16) . Gene knock-down of HSL only decreased catecholamine-stimulated lipolysis. Similar results were obtained with FFA and glycerol measurements. These results suggest a critical role for ATGL as a regulator of both basal (i.e. spontaneous) and stimulated lipolysis while HSL only determines stimulated lipolysis.
In contrast to these findings primarily obtained in rodents, the role of ATGL in humans is much less clear. An association between single nucleotide polymorphisms in the ATGL gene and circulating levels of FFA, TG and risk for type 2 diabetes mellitus was recently demonstrated (27) . Moreover, mutations in the CGI-58 gene are associated with ChanarinDorfman Syndrome, a rare genetic disease characterized by excessive TG accumulation in non-adipose tissues. Recently, the importance of ATGL in human lipolysis was indirectly determined using a selective inhibitor of HSL in adipocytes from healthy donors (17) . It was found that catecholamine or natriuretic peptide-stimulated lipolysis was completely inhibited whereas basal lipolysis was only partially abrogated. This suggests that HSL is the major rate limiting lipase in human lipolysis and that ATGL may above all play a role in the regulation of basal lipolysis. Other human studies demonstrated that ATGL mRNA, as opposed to HSL mRNA expression, is not regulated by obesity and that the in vitro TG hydrolase activity of ATGL, in the absence of CGI-58, is substantially lower than that of HSL (22) . Thus, the enzymatic contributions of HSL and ATGL to TG hydrolysis and thereby lipolysis may differ between humans and rodents. However, the comparison between HSL and ATGL is incomplete so far in man since there is no information on ATGL protein levels or effects of genetic manipulation of lipase expression in relation to lipolysis in human fat cells.
In the present study, we have compared the physiological roles of HSL and ATGL in human fat cell lipolysis. This was done through parallel determinations of protein level, adipocyte Page 4 of 29 lipolytic activity, and modulation of HSL and ATGL levels using RNAi technology. We also compared their expression in conditions with altered lipolysis namely obesity and polycystic ovary syndrome, which are two conditions with decreased expression and function of HSL (1).
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Material and Methods
Subjects
One cohort consisted of obese women who underwent bariatric surgery or gall stone operations (n=19) or were investigated as healthy volunteers (n=8 Subjects from all four cohorts included in this study were healthy and free of medication. The studies were approved by the ethical committee at Karolinska Institutet and explained in detail to each of the subjects, from whom informed consent was obtained.
Lipolysis assessment in mature fat cells and predipocyte cultures
Lipolysis experiments in mature fat cells were performed as described in detail previously (22) . In brief, cells were incubated in an albumin-containing buffer (pH 7. 
Studies of hMSCs
Human MSCs were obtained from adult adipose tissue and differentiated into the adipogenic lineage as described in detail elsewhere (3) . We have previously shown that these cells display lipolytic activity comparable with differentiated human preadipocytes. hMSC derived from two different donors were used. Functional assessment of adipocyte differentiation was performed by determining glycerol-3-phosphate dehydrogenase (GPDH) activity as described previously (31). Cells from two wells were washed with phosphate buffered saline (PBS) (pH 
previously been described in detail (17) and was used at the concentration of 1 µM. Following incubation, medium was removed and kept at -20 o C for subsequent measurement of glycerol concentration (an index of lipolysis) using a bioluminescence method (13) .
Protein expression of HSL and ATGL
Approximately 300 mg of WAT was crushed and lysed in protein lysis buffer (1% Triton-X 100, Tris-HCL pH 7.6 and 150 mmol/L NaCl, 4ºC), supplemented with protease inhibitors (1 mmol/L PMSF and Complete® (Boehringer Mannheim, Mannheim, Germany), and homogenized using a microtome. The homogenate was centrifuged at 14,000 rpm for 30 min, and the infranatant was collected and saved. Protein content was assayed using BCA Protein Assay Reagent Kit (PIERCE, Rockford, IL, USA) as described above. In order to test if proteins remained in the fat cake following our protein extraction procedure we performed the following control procedure. The fat cake was removed and subjected to methanol-CHCl 3 extraction (23) which effectively collects all proteins. These extracted proteins were dissolved in the same lysis buffer as above. Protein levels in fat cake extracts were below the detection limit of our assay. Thus, there are insignificant amounts of lipases left in the fat cake. One hundred micrograms of total cellular protein was loaded on polyacrylamide gels and separated by standard 12% SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis).
Gels were transferred to PVDF (polyvinylidine fluoride) membranes (Amersham Pharmacia
Biotech, Little Chaffore, U.K.). For HSL and -actin detection, blots were blocked for 1 h at room temperature in Tris-buffered saline with 0.1% Tween-20 and 5% non-fat dried milk.
This was followed by an overnight incubation at 4°C in the presence of antibodies directed against HSL or protein -actin (SIGMA, St Louis, USA). The human-specific HSL antibody was a generous gift from C Holm (Lund University, Sweden) and has been characterized elsewhere (8) . For the detection of ATGL, an affinity purified polyclonal antibody was raised in rabbit against a 15 amino-acid peptide (amino-acids 386-400, GRHLPSRLPEQVERL) of human ATGL. To test antibody specificity we expressed ATGL protein in COS cells by transfection with cDNA coding for human ATGL. For detection of ATGL the following conditions were used. Blocking was performed in phosphate buffered saline (PBS)
supplemented with 4% BSA. This solution was used for antibody incubation after addition of 0.1% Tween-20 while PBS+0.1% Tween-20 was used as wash solution. All incubations with the ATGL antibody were performed at room temperature. Secondary -rabbit antibodies conjugated to horseradish peroxidase were from Sigma (St. Louis, MO). Antigen-antibody complexes were detected by chemiluminescence using a kit of reagents form Pierce (Supersignal; Rockford, Rockford, IL) and specific bands were detected using a Chemidoc XRS system (BioRad, Germany). Images were analyzed using the Quantity One Software supplied by the manufacturer (BioRad). To control for differences in loading etc, -actin was used as a control protein and values for HSL and ATGL were expressed as the quotient toactin in relative units (RU). Furthermore, proteins from two subjects were ran on all gels in order to ensure similar exposure times etc to further improve interexperimental comparison.
RNA interference
RNAi in human preadipocytes was essentially performed as described previously using short interfering RNA oligonucleotides (siRNA) (25). For each oligonucleotide, optimal transfection conditions were determined in separate titration experiments using different amounts of siRNA oligonucleotides (Qiagen GmbH, Hilden, Germany) and transfection reagent RNAiFect® (Qiagen GmbH, Hilden, Germany). Cells at day 12 of differentiation (a time-point where the cells are almost fully differentiated) were transfected with or without ATGL or HSL siRNAs (Qiagen GmbH, Hilden, Germany). The siRNA sequences were (sense strand): ATGL 5'-CGG CGA GAA UGU CAU UAU, HSL 5'-GCC UGC UUC AAA CCA AAG A. To control for unspecific RNAi effects, control cells were transfected with non-silencing siRNA oligos without known similarities to human sequences (Qiagen GmbH, Hilden, Germany). Cells were incubated for 24 h, a time-point where a significant gene silencing effect was observed. Conditioned cell media aliquots were then analyzed for glycerol content while cells were lysed for RNA or protein isolation as indicated above to confirm gene silencing.
RNA analysis
Total RNA from preadipoyte cultures were extracted using the RNeasy mini kit (Qiagen, Hilden, Germany). RNA concentration and purity was assessed spectrophotometrically. A bioanalyser (Agilent 2100, Agilent Technologies, Kista, Sweden) was used to confirm RNA integrity. One microgram of total RNA was reverse transcribed using a kit (Omniscript RT, Qiagen) and random hexamers (Invitrogen, Tåstrup, Denmark). To minimize methodological errors due to variation in cDNA-synthesis, cDNA-synthesis was performed simultaneously for all subjects included in the analysis. PCR conditions and primers for HSL, ATGL and 18S
have previously been described (22) . The primer pairs were selected to yield a single amplicon based on dissociation curves and analysis by agarose gel electrophoresis.
Quantitative real-time PCR was performed in an iCycler IQ TM (Bio-Rad Laboratories Inc., Hercules, CA, USA). In RNAi experiments, ATGL and HSL mRNA levels were significantly reduced to less than 20% of that in control cells and each condition was repeated at least three times with cells from different donors. Experiments where gene silencing was not efficient were discarded and not used for further analysis.
Statistical Analysis
Values are given as mean±standard error (SE). They were compared with Student's unpaired t-test, ANOVA, post-hoc tests and linear regression analysis using standard software packages. A P-value of 0.05 or less was considered to be statistically significant. It is difficult to find young, lean and otherwise healthy women with PCOS. Prior to recruitment, we made a power calculation for the comparison of lean, young women with or without PCOS based on previous findings with HSL protein expression and lipolysis (8) . We can detect a 20% difference between groups in either result with P<0.05 and with a power of 80% by investigating, as performed in this study, 12 control and 8 PCOS subjects.
Drugs and chemicals
Bovine serum albumin (BSA) fraction V (lot no. A-9418), glucose, glycerol kinase, and noradrenaline, were obtained from Sigma Chemical (Sigma, St. Louis, MO, USA). All chemicals used were of the highest grade of purity that was commercially available.
Results
Clinical data
The clinical findings in cohort 1-3 are shown in Table 1 . The obese subjects were insulin resistant and somewhat older than the other groups. Healthy lean and PCOS women had almost identical BMI, age and insulin sensitivity but the PCOS subjects had a 4-fold higher testosterone/SHBG ratio.
Methodological experiments
Similar concentrations of protein (3-6 µg/µl) were obtained in the tissue extracts. However, no protein was detected in the extracts from the fat cake (detection limit is 0.01 µg/µl).From 
Glycerol release following down regulation of HSL and ATGL by RNA interference
We used RNA interference to determine the effects of selective lipase down-regulation on basal and catecholamine (i.e. isoprenaline)-stimulated lipolysis in differentiated human preadipocytes. This system was chosen since we have recently developed efficient RNAi protocols in these cells (25) and since freshly isolated mature fat cells display a limited survival in vitro (hours). Lipolysis was determined as glycerol release. We also attempted to measure FFA release using a sensitive chemiluminescence method as well as gas chromatography, but the concentrations were below threshold sensitivity for the assays (data not shown). To control for non-specific effects of siRNA, scrambled non-silencing oligonucleotides were used to transfect control cells under otherwise identical conditions.
Using either siRNA directed against HSL or ATGL we were able to down regulate HSL and ATGL mRNA in the same order of magnitude (15±2.5 and 12±4 %, respectively, n=4, Figure   1B ). There was no effect of ATGL oligonucleotides on HSL mRNA expression or vice versa ( Figure 1B ) nor of control (scrambled) oligonucleotides (data not shown). Moreover, down regulation of mRNA resulted in a clearly observable reduction of the cognate protein down to about 30 % (35±3.5 and 32±2.5 %, for HSL and ATGL vs control, respectively, P<0.01, n=4, Figure 1C ). Following down-regulation of HSL, a 35% decrease of both basal (P=0.028, Figure 1D ) and isoprenaline-stimulated lipolysis (P=0.017, Figure 1E ) was observed. In contrast, RNAi knock-down with siRNA oligonucleotides specific for ATGL decreased basal lipolysis by 40% (P=0.018, Figure 1D ) but had no effect on isoprenaline-induced lipolysis (P=0.73, Figure 1E ).
Lipolysis in hMSC
The role of HSL for lipolysis in adipocyte precursor cells was examined using the selective HSL inhibitor BAY at the maximum effective concentration (Figure 2 ). This inhibitor does not influence any other lipase apart from HSL, including ATGL. We chose to use a recently established cell system based on hMSC isolated from human adipose tissue. These cells can be efficiently differentiated in vitro into adipocytes and display all the morphological and functional characteristics of human adipocytes (3). Furthermore, these are the only human cells that can be used to block HSL from the earliest stage of differentiation since preadipocytes are committed to the adipogenic lineage. hMSC were allowed to proliferate and then differentiate into fat cells. Thereafter, a 3-hour lipolysis experiment was performed.
Inhibiton of HSL with BAY after adipose differentiation (con-bay) reduced basal lipolysis by half and almost completely counteracted lipolysis stimulated by isoprenaline, noradrenaline and the 2 adrenergic receptor inhibitor yohimbine, a cyclic AMP analogue (dcAMP) and atrial natriuretic peptide (ANP, which stimulates lipolysis via the cyclic GMP pathway) compared with control cells not exposed to BAY (con-con, Figure 2 , P<0.05, n=5). Almost identical results as with con-bay treated cells were obtained with hMSC-derived adipocytes continuously exposed to BAY during the entire experiment, i.e. during the differentiation process as well as the lipolytic experiment (bay-bay). In contrast, cells exposed to BAY during differentiation but not during the lipolytic assessment (bay-con) displayed a lipolytic response that was very similar to control cells (con-con). BAY treatment did not influence adipocyte differentiation of hMSCs according to measurements of GPDH activity (not shown).
Lipolysis and lipase protein expression in lean controls, obese and lean PCOS subjects
In order to compare lipolysis and HSL or ATGL levels in subjects with different lipolytic capacity we investigated lean, obese and PCOS-subjects. Catecholamine-induced lipolysis (in mature adipocytes) and protein expression (in adipose tissue) of ATGL and HSL were Figure 3A ). Basal rate of glycerol release was similar in lean controls and PCOS subjects but slightly increased in the obese (P=0.056, graph not shown). HSL protein levels were 50-65% decreased in PCOS and obese subjects ( Figure 3B, 
P=0.0022).
Post-hoc analysis of HSL data revealed a significant difference between lean versus obese (P=0.0005) and PCOS versus lean (P=0.046) but there was no significant difference between obese and PCOS. In contrast there was no difference in ATGL protein levels between the three groups (P=0.96, Figure 3C ). The mean value for obese and PCOS was identical (1.75 RU). The value for lean controls was 10% lower than that for obese subjects. -actin expression was similar in the three groups and used to correct values to enable comparison between blots.
Since obese women were somewhat older than lean and PCOS women, values for lipolysis and protein expression were also corrected for age in the ANOVA analysis (i.e ANCOVA).
This did not alter the outcome of the results. We also excluded the obese undergoing general surgery. The results with the remaining 8 obese investigated as the lean and PCOS women were the same as for the whole group except that this obese subgroup had almost the same mean age as the two other groups (30.5 years).
The expression of HSL and ATGL protein from the obese, lean and PCOS subjects was plotted against maximal lipolytic capacity (expressed as noradrenaline/basal lipolysis). There was a positive correlation between HSL levels and lipolysis ( Figure 3D , P<0.0001, R=0.72).
In contrast, we observed no significant correlation between ATGL protein expression and lipolysis although a slight negative trend was observed (graph not shown, P=0.15, R=-0.23).
We also expressed noradrenaline-induced glycerol release in absolute values corrected for remained in the fat cake using our protein extraction protocol. In addition, the HSL inhibitor has no effect on other lipases at the concentration used in this study.
Due to the difficulties in recruiting lean PCOS subjects the number of these women and their matched controls was limited. However, our power calculation prior to recruitment showed that the number of subjects was large enough to significantly detect the observed differences.
Although there was a small difference in age between obese and the other two study groups, age correction of results and a subgroup analysis showed that there was no significant effect of age on these results. We found a positive correlation between HSL, but not ATGL, protein levels and lipolytic capacity in response to catecholamines. This indicates that HSL is more important in promoting catecholamine-stimulated lipolysis at least when considering complete hydrolysis of TG into glycerol and FFA. There may also be incomplete lipolysis resulting in the formation of DG from TG (2) and the DG pool in human adipose tissue, although small (~1 % of all lipids), is subject to rapid turnover (5). We can therefore not exclude the possibility that ATGL, with its' high affinity to TG, is more important than HSL for the regulation of incomplete lipolysis (TG to DG) resulting in release of FFA but not glycerol that occurs in human fat cells. In order to answer this question it is necessary to measure DG and FFA. Unfortunately, although we have developed among the most sensitive assays for the measurements of glycerol (end product in DG analysis) and FFAs in human fat cells, the amounts of FFAs released from our primary cultures and the intracellular levels of DG were below the detection limit of our methods. Therefore, at present, such experiments cannot be performed. However, our results are valid for complete hydrolysis of TG or DG which always results in the release of glycerol.
Little is known regarding the regulation of ATGL expression in man although adipose tissue mRNA expression was not altered by obesity. This was in contrast to HSL mRNA which was significantly down-regulated in this condition (22) . We presently compared activation of basal lipolysis with lipase protein expression in subcutaneous adipose tissue of lean, obese and lean PCOS women. Noradrenaline-induced lipolysis and HSL expression is decreased in the latter two states as reviewed (1) . Obesity is associated with insulin resistance and some PCOS women are also insulin resistant. The PCOS subjects included in this study displayed no insulin resistance, presumably because they were young and lean. This confirms findings in a similar cohort of PCOS women investigated previously (8) . We could also confirm previous findings from our laboratory, namely that lean, non-insulin resistant PCOS and obese insulin resistant women have a blunted catecholamine-induced lipolysis and reduced HSL expression (6, 8) . More important is the concomitant observation that ATGL protein expression is not altered at all in obesity or PCOS. These results give further support to the notion that ATGL plays a less important role in regulating catecholamine-stimulated lipolysis in human fat cells.
It is possible, though, that there is not a simple one-to-one relationship between HSL expression and lipolysis activation. Firstly, there was a considerable dispersion in the relationship between HSL and lipolysis in Figure 3D . Secondly, although lipolysis activation was almost identical in obese and PCOS ( Figure 3A ), HSL expression was slightly but not significantly lower in obese than in PCOS women ( Figure 3B ).
Although the data discussed so far favour HSL over ATGL in lipolytic regulation by The RNAi results obtained in these primary human cells contrast findings in a murine preadipocyte cell line (16) . We used the same protocols (decreasing gene expression of ATGL or HSL with siRNA and measuring basal and isoprenaline-induced glycerol release). The earlier study (16) also reported data on fatty acids. As mentioned above, we were not able to measure these lipids although we used an ultra sensitive bioluminescence assay. Nevertheless, the murine study showed that ATGL is important for basal and stimulated lipolysis while HSL is mainly required for stimulated lipolysis in adipocytes. This is not the only regulatory aspect of lipolysis that is subject to major species differences when results of human and murine fat cells are compared (for reviews see (1) In fact, recent data suggest that the regulation of enzyme activity of HSL and ATGL is more complex than previously recognized (10 
